baber/WOPTO huggingface dataset:
Patent FI-934602-A0 (FI)
Inventor: STOCK DIETER
IPC: C23C4/123
Filed: 1993-10-19
Abstract: The invention relates to a semi-finished product, in particular of copper or copper alloys, which is produced from a rotationally symmetrical preform (1) by hot and cold forming steps. The preform (1) itself is produced by spray compacting and consists of a core (9) and at least one outer layer (10) which is disposed around said core, which, as a result of modifying additives, with the formation of a flowing boundary, have variable properties. Suitable modifying additives are particles which are insoluble in the metal matrix and are introduced either into the core (9) or into the outer layer (10), or they are heterogeneous insoluble particles which are introduced both into the core (9) and into the outer layer (10). <IMAGE>
Patent FI-935851-A0 (FI)
Inventor: IKEJIRI YOSHIFUMI
IPC: A61P11/02
Filed: 1993-12-23
Abstract: There is disclosed an antiallergic composition for ophthalmic or nasal use, comprising cetirizine or a salt thereof as an active ingredient. The antiallergic composition may further contain a cyclodextrin compound, as well as a surfactant and/or a water soluble polymer.
Patent FI-943946-A0 (FI)
Inventor: ALBREKTSSON BJOERN
IPC: A61F2/46
Filed: 1994-08-26
Abstract: A fixture for a hip joint prosthesis for permanent anchorage in a human hip joint in the neck 6 of a human femur. The fixture includes a cylindrical forward section having forward and rearward portions 1, 2 made as one integral part and provided with cylindrical outer surfaces with external self-tapping threads 3, 15, the diameter of the rearward portion 2 being greater than that of the forward portion 1. The fixture also comprises a rearward section having a circumferential collar 16 for abutting the cut end surface of the femur neck 6, thereby delimiting the insertion of the fixture into the femur neck 6. The rearward section further has a rearward portion in the shape of a truncated cone 13 which tapers outwardly in the forward direction for engagement in a complementary conical recess 19 in a prosthetic ball unit 18. <IMAGE>
Patent FI-945079-A0 (FI)
Inventor: GUIDOTTI TED
IPC: A61F13/53
Filed: 1994-10-28
Abstract: PCT No. PCT/SE93/00348 Sec. 371 Date Oct. 14, 1994 Sec. 102(e) Date Oct. 14, 1994 PCT Filed Apr. 21, 1993 PCT Pub. No. WO93/21882 PCT Pub. Date Nov. 11, 1993An absorbent body intended to form the absorbent element of an absorbent article, such as a diaper, an incontinence guard or a sanitary napkin, includes a first fibre-based absorbent layer which lies proximal to the wearer in use, and a second, fibre-based absorbent layer which is intended to lie distal from the wearer in use, this second layer having a high liquid-dispersing ability. An absorbent body exhibiting particularly good absorption properties has been obtained by including in the first layer (16) a superabsorbent material (18) of high gel-strength and by mixing this superabsorbent essentially uniformly in the fibre material within at least one area of the layer, and by including between the fibre layers (17a, 17b) of the second layer (17) a layer (20) of superabsorbent material.
Patent FI-960567-A0 (FI)
Inventor: FUKUSHIMA NAOSHI
IPC: A61K38/00
Filed: 1996-02-07
Abstract: A monoclonal antibody that induces apoptosis in the myelocytic cell, a fragment of the antibody, and a hybridoma that produces the antibody. The antibody is useful as an antibody that specifically recognizes an antigen or the like inducing apoptosis in the myelocytic cell and discriminates and identifies the same. Further it is useable as a useful drug in the field of, for example, treating myelocytic leukemia by utilizing the activity of inducing apoptosis in the myelocytic cell.
Patent FI-963224-A0 (FI)
Inventor: HEARD TONY
IPC: B05B15/00
Filed: 1996-08-16
Abstract: PCT No. PCT/GB95/00275 Sec. 371 Date Jul. 30, 1996 Sec. 102(e) Date Jul. 30, 1996 PCT Filed Feb. 10, 1995 PCT Pub. No. WO95/22409 PCT Pub. Date Aug. 24, 1995An improved spray gun having an aluminum gun body and a sprayhead made of a plastics material, preferably of polybutylene terephthalate. The sprayhead is permanently secured to the spray gun body, preferably with a swaged ring of stainless steel. The spray gun may be provided with a plastic handle which is preferably formed from polybutylene with 10% of a polyester elastomer. In one embodiment, the sprayhead is oriented relative to the gun body prior to securing to select either gravity feed or suction feed for the sprayed fluid.
Patent FI-963232-A0 (FI)
Inventor: BENJAMIN NIGEL
IPC: A61P31/04
Filed: 1996-08-16
Abstract: The invention relates to the use of acidified nitrite as an antimicrobial agent and describes a dosage form for use in the treatment of bacterial, viral or fungal conditions. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the pH at the environment. Amongst the many potential applications for the invention, the inventive composition has been shown to be particularly effective as an animal feed supplement, and as an agent for sterilising objects. Compositions and methods of use for these applications are described.
Patent FI-963287-A0 (FI)
Inventor: ROSEN PER
IPC: F02B3/06
Filed: 1996-08-23
Abstract: PCT No. PCT/SE95/00026 Sec. 371 Date Oct. 8, 1996 Sec. 102(e) Date Oct. 8, 1996 PCT Filed Jan. 16, 1995 PCT Pub. No. WO95/23286 PCT Pub. Date Aug. 31, 1995The invention relates to a method for supplying vapor to intake air that is supplied to an internal combustion engine. The method comprises the steps of compressing the intake air before supplying the vapor and contacting, in a moistening means, the intake air with liquid, by simultaneously feeding the compressed intake air and the liquid into the moistening means and causing the intake air and the liquid to flow in opposite directions through the moistening means. The invention also relates to a device for supplying vapor to the intake air of an internal combustion engine, to which a compressor for compressing the intake air is connected. The device comprises a moistening means, which is connected between the compressor and the engine and which comprises a first connection for feeding the water into the moistening means and a second connection for feeding the intake air into the moistening means, the moistening means being adapted to carry out the supply of water vapor to the intake air by contacting the intake air and the water with each other, while flowing in opposite directions through the moistening means.
Patent FI-963505-A0 (FI)
Inventor: LAEREMANS ETIENNE
IPC: H02G15/013
Filed: 1996-09-06
Abstract: PCT No. PCT/GB95/00469 Sec. 371 Date Dec. 2, 1996 Sec. 102(e) Date Dec. 2, 1996 PCT Filed Mar. 6, 1995 PCT Pub. No. WO95/24756 PCT Pub. Date Sep. 14, 1995A sealing apparatus for sealing an end of an enclosure having an opening for passing an elongate object, such as a cable, therethrough is disclosed. The sealing apparatus includes a sealing device with a port through the sealing device. The sealing device is configured so as to be placed within an end of the enclosure and in sealing engagement with an inner surface of the enclosure. An adaptor is further disclosed which is configured to be inserted within the port of the sealing device. An opening is provided in the adaptor for receiving the elongate object to be passed into the enclosure. The adaptor further includes a first compressing part and a second compressing part longitudinally offset from the first compressing part with a sealant disposed between the compressing parts. A driver in the sealing device is operatively connected to the compressing parts to position the compressing parts in longitudinally movable positions relative to each other. Longitudinal movement of the compressing parts towards each other compresses the sealant into contact with an elongate object in the opening of the adaptor. Sealing methods are also disclosed utilizing the apparatus of the present invention.
Patent FI-970182-A0 (FI)
Inventor: ST CLAIR DAVID JOHN
IPC: C08G59/34
Filed: 1997-01-16
Abstract: The present invention provides a toughened cycloaliphatic epoxy resin composition useful as a coating comprising: (a) a curable cycloaliphatic epoxy resin, (b) an epoxidized low viscosity polydiene polymer wherein the polymer contains from 2.0 to 6.0 milliequivalents of epoxy per gram of polymer, (c) a curing agent, (d) an aromatic epoxy resin, and (e) a hydroxy functional material.
Patent BE-1005405-A0 (BE)
Title: Centrifugeuse a axe de rotation vertical.
Inventor: GRAW GEORG
IPC: B04B11/08
Filed: 1991-05-06
Abstract: Centrifugeuse dont le tambour centrifuge présente une chambre de pelage (2) reliée à la chambre de séparation du tambour par un canal de déviation (12) et présentant un dispositif de pelage (3), servant à une déviation continue d'une phase liquide séparée dans le tambour, ainsi qu'un disque d'arrêt (5) relié de manière fixe au dispositif de pelage dans une chambre d'arrêt (6) tournant avec le tambour, le dispositif de pelage étant pourvu d'un canal (9) d'amenée de gaz sous pression dans la zone située en dessous du disque d'arrêt et d'un canal (10) d'amenée de liquide d'obturation dans la chambre d'arrêt, celle-ci étant, dans sa zone périphérique, reliée au canal de déviation (12) par au moins un premier canal (11).
Patent IL-62864-A0 (IL)
Title: Process for the preparation of trimethylsilyl cyanide
IPC: C07F7/12
Filed: 1981-05-13
Abstract: A process for the preparation of trimethylsilyl cyanide comprising reacting trimethylsilyl chloride with an approximately equimolar amount of an alkali metal cyanide in the presence of a catalytic amount of a heavy metal cyanide and in the presence of an aprotic solvent with a boiling point above about 150 DEG  C., at a temperature between about 130 DEG  and 250 DEG  C. Advantageously the reaction temperature is between about 160 DEG  and 220 DEG  C., the alkali metal cyanide is sodium cyanide or potassium cyanide, the heavy metal cyanide is copper(I) cyanide, copper(II) cyanide, zinc cyanide or a complex compound of one of them with an alkali metal cyanide and is employed in about 1 to 8 mol % relative to the alkali metal cyanide, and the mixture of aprotic solvent, heavy metal cyanide and alkali metal chloride remaining in the reaction vessel when the reaction has ended is used directly as the reaction medium for a further batch.
Patent IL-62894-A0 (IL)
Title: Dibenzoxazepine derivative,process for preparing the same,and pharmaceutical composition comprising the same
IPC: A61K31/55
Filed: 1981-05-18
Abstract: Dibenzoxazepine derivatives of the formula:  <IMAGE>  wherein R1, n, R2 and R3 are as defined in the description, process for preparing the same, pharmaceutical composition containing the same and method of treating diseases in circulatory organs administering the composition to a patient are disclosed. The compounds of the formula have lipid lowering activity, lipid peroxide lowering activity, blood sugar lowering activity and activity to inhibit the aggregation of platelets, and hence are useful as a medicine.
Patent IL-74392-A0 (IL)
Title: Manufacture of sodium perborate monohydrate from sodium perborate tetrahydrate
IPC: C01B15/12
Filed: 1985-02-20
Abstract: 1. Process for the manufacture of sodium perborate monohydrate by dehydration of sodium perborate tetrahydrate by heating under reduced pressure, characterized in that this dehydration is performed at an absolute pressure which is maintained between 0.03 and 0.13 bar at a temperature of the mass which is to be dehydrated not exceeding 70 degrees C, without any gas stream being allowed to enter the dehydration zone.
Patent IL-81610-A0 (IL)
Title: Derivatives of 1,2,5,6-tetrahydropyridine-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
IPC: C07D211/28
Filed: 1987-02-18
Abstract: Compounds useful in the treatment of Alzheimer's disease, senile dementia, or memory disorders which have the formula   <IMAGE>   in which R represents a hydrogen atom, a linear, branched or cyclic alkyl radical, saturated or unsaturated, containing up to 8 carbon atoms, possibly substituted by a free or esterified carboxy radical or R represents an aralkyl radical containing up to 10 carbon atoms and R' represents a linear or branched, saturated or unsaturated, alkyl radical, containing up to 8 carbon atoms, a radical -COalk1 or a radical -(CH2)2N(alk2)2, alk1 and alk2 representing an alkyl radical containing up to 8 carbon atoms, as well as their addition salts with acids. Also compositions containing the same, method of preparation and method of treatment using the same.
Patent IL-93473-A0 (IL)
Title: Antiinflammatory benzoxazolones
IPC: A61P29/00
Filed: 1990-02-21
Abstract: This invention relates to certain benzoxazolinones which inhibit lipoxygenase and/or cyclooxygenase enzymes. Such compounds are useful in inhibiting such enzymes, per se, and are useful in treating allergic and inflammatory conditions in a mammal. This invention also relates to methods of inhibiting lipoxygenase and/or cyclooxygenase in a mammal with such benzoxazolinones; methods of treating an allergic condition in a mammal with such compounds; methods of treating an inflammatory condition in a mammal with such compounds; and pharmaceutical compositions comprising the benzoxazolinones hereof.
Patent IL-94420-A0 (IL)
Title: Isotropic pharmaceutical preparation and process for the preparation thereof
IPC: A61K39/395
Filed: 1990-05-16
Abstract: Pharmaceutical preparation consisting of one or more active ingredients and an excipient which solidifies at temperatures between 20 and 80 DEG C and is water soluble, characterized in that it is an isotropic solution in which a) the active ingredient is dissolved in monomolecular or ionic form in the excipient, b) the active ingredient is present in its native conformation and/or its biologically active chiral (enantiomeric) conformation, c) the active ingredient has a mol fraction of 0.001 to 0.67 at 37 DEG C, d) at body temperature, the excipient is molten, single-phase and isotropic, e) the isotropic solution, consisting of excipient and active ingredient, solidifies at ambient temperature, f) the solidified solution is crystalline or non-crystalline or it contains the active ingredient in crystalline form or the latter can crystallize out of the solidified solution, g) the monomolecular or ionic solution has an osmotic pressure and depresses the molar freezing point, h) the dissolved active ingredient present in the polymer electrolyte has a temperature-dependent specific conductivity. A process for obtaining this pharmaceutical preparation is also described.
Patent FI-20000533-A0 (FI)
Inventor: TAKALA HEIKKI
IPC: B01F23/30
Filed: 2000-03-09
Abstract: Leaching of solid matter from a sludge uses a tubular reactor which is equipped with a concentric central pipe and a double-action mixer. The mixer is located in the vicinity of the central pipe's lower edge. Leaching solid matter from a sludge with the aid of an oxygen-containing gas uses a tubular reactor. The reactor is equipped with a concentric central pipe (2), and a double-action mixer (5) in the vicinity of central pipe's lower edge (7). With the aid of the mixer, the sludge flows downward in the central pipe, and then turns upward outside the central pipe as the gas is fed at the same time into the sludge and dispersed into small bubbles. The mixer preferably has nearly rectangular straight lower blades which facilitate the dispersion of the gas and the turning of the discharge sludge into the upward flow. It has curved upper blades which facilitate the downward flow of the sludge in the central pipe. It is preferred that the cross-section area remaining between the mixer and the central pipe is adjusted to be less than half (preferably at most one third) of the flow cross-section area in the central pipe and the lower edge of the central pipe is at a height (measured form the reactor bottom) of 0.7-1.3 times that of the reactor diameter, preferably the same as the diameter. The cross-section ratio of the central pipe and its surrounding reactor casing is preferably below 0.1.
Patent FI-20031893-A0 (FI)
Inventor: HYVOENEN JORMA
IPC: A01G23/091
Filed: 2003-12-22
Abstract: An arrangement in connection with a crosscutting saw of a harvester. Herein, a lattice-like structure composed of strips is provided in a saw casing of the crosscutting saw, the structure being substantially on the same section plane as the rotational movement of a chain of the crosscutting saw. The strips are arranged in the saw casing in such a manner that substantially each movement path tangent generated at a lower edge in a guide bar of the chain or at an outer track on the side of the saw casing in the chain wheel is arranged to encounter a surface in the strip. This provides a structure that enhances a controlled removal of sawdust or other pieces flowing to the saw casing during sawing.
Patent IL-131129-A0 (IL)
Title: Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp infection
IPC: A61K31/52
Filed: 1998-02-05
Abstract: An oral preparation for the prophylactic and/or therapeutic treatment of inflammation in the mucous membrane of mammalian gastrointestinal tract (especially the human stomach) caused by Hicobacter sp. (especially H. pylori) infection is described. The preparation comprises a prophylactically and/or therapeutically effective amount of at least one type of xanthophylles. The most preferred xanthophyll is astaxanthin which is soluble in oil, preferably naturally produced astaxanthin which is esterified with fatty acids. The oral preparation may further comprise carbohydrate structures, such as those which derive from the cell wall of the production alga Haematococcus sp. The preparation may also comprise a prophylactically and/or therapeutically effective amount of a water soluble antioxidant, such as ascorbic acid (vitamin C). The oral preparation is presented in a separate unit dose or in mixture with food.
Patent IL-131581-A0 (IL)
Title: Cycloalkylalkanecarboxamides and the production and use thereof
IPC: C07C233/13
Filed: 1998-02-23
Abstract: The present invention relates to novel cycloalkylalkane-carboxamides of the formula Iwhere the substituents have the following meanings:A is C3-C6-cycloalkyl;R1 is C1-C6-alkyl or C2-C6-alkenyl;R2, R3 and R4 are hydrogen or, independently of this meaning, have one of the meanings of the radical R1;n is 0 or 1;Y is cyano or halogen;w is phenyl, naphthyl or heteroaryl.
Patent IL-141481-A0 (IL)
Title: Method for detection of biological factors in epidermis
IPC: C12N15/12
Filed: 1999-08-17
Abstract: Disclosed is a method for removing polynucleotide from the skin. This polynucleotide can be used to detect dermatitis and distinguish an irritant reaction from an allergic reaction by characterizing the polynucleotide according to the polypeptide which it encodes. Additionally, provided are methods for non-invasive isolation of samples from the skin as well as kits for use in the methods provided herein.
Patent IL-144969-A0 (IL)
Title: Synchronization and cell search method and apparatus for wireless communications
IPC: H04B1/7083
Filed: 2000-03-03
Abstract: A received communications signal is correlated with a common synchronization code to produce a synchronization detection signal. A component of the synchronization detection signal associated with a known synchronization signal is canceled from the synchronization detection signal to produce an interference-canceled synchronization detection signal. Timing of a synchronization signal is determined from the interference-canceled synchronization detection signal. According to one aspect, interference cancellation is achieved by generating a correlation of an estimated received known synchronization signal with the common synchronization code, canceling the correlation of the estimated received known synchronization signal with the common synchronization code from the synchronization detection signal to produce the interference-canceled synchronization detection signal. Timing of a synchronization signal may then be determined by accumulating the interference-canceled synchronization detection signal over a time interval, detecting a peak in the accumulated interference-canceled synchronization detection signal, and determining timing of a synchronization signal from the detected peak. According to another aspect, interference cancellation is achieved by accumulating the synchronization detection signal over a time interval, identifying a peak in the accumulated synchronization detection signal not associated with a known synchronization signal, and determining timing of a synchronization signal from the identified peak. Related terminal apparatus are also discussed.
Patent IL-146702-A0 (IL)
Title: Method and device for monitoring the creation and destruction of child processes within an application executing in a computer system
IPC: G06F11/00
Filed: 2000-05-24
Abstract: A method and a virtual device driver for monitoring the creation and destruction of child processes or threads within an application executing in a computer system controlled by an operating system, such as Windows. A list is provided for storing existing child process database structures corresponding to child processes existing within the executing application. The list is checked periodically. If, when checked, the list has no entries, it is safe to assume that the existing child process and, possibly, related grandchild processes, have exited and execution of the application is complete. Other applications in a series of applications, for example, during the installation of a software program, may then be executed with minimal risk of corruption due to concurrent execution of the applications in the series.
Patent IL-147180-A0 (IL)
Title: Method for preventing tumoral growth
IPC: A61K38/00
Filed: 2000-06-21
Abstract: A method for preventing inflammations, auto-immune diseases and tumoral growth, whereby LTBR-mediated activation is suppressed.
Patent IL-147398-A0 (IL)
Title: Process for the preparation of l-amino acids from their racemic n-acetyl-d, l derivatives by enzymatic resolution by means of isolated, recombinant enzymes
IPC: C12P13/04
Filed: 2000-06-17
Abstract: Process for the preparation of L -amino acids from their racemic N-acetyl-D,L derivatives by enzymatic resolution by means of isolated, recombinant enzymesA process for the preparation of proteinogenic or nonproteinogenic L-amino acids, in particular L-phosphinothricin, from their racemic N-acetyl-D,L derivatives comprisesa) selectively deacetylating N-acetyl-L derivatives of the corresponding L-amino acids by an enzymatic resolution by means of isolated, recombinant enzymes, while N-acetyl-D derivatives of the corresponding D-amino acids are not deacetylated and(b) separating the deacetylated L-amino acids obtained preparatively from the nondeacetylated N-acetyl-D derivatives and/or the incompletely deacetylated N-acetyl-L derivatives.
Patent IL-148304-A0 (IL)
Title: Oligonucleotide n3'-p5' thiophosphoramidates, their synthesis and use
IPC: C12N15/11
Filed: 2000-09-08
Abstract: Oligonucleotides with a novel sugar-phosphate backbone containing at least one internucleoside 3'-NHP(O)(S-)O-5' linkage, and methods of synthesizing and using the inventive oligonucleotides are provided. The inventive thiophosphoramidate oligonucleotides were found to retain the high RNA binding affinity of the parent oligonucleotide N3'P5' phosphoramidates and to exhibit a much higher acid stability.
Patent IL-152547-A0 (IL)
Title: Improved process for the measurement on non-transferrin bound iron
IPC: G01N/
Filed: 2001-04-29
Abstract: A molecule suitable for use as an indicator of free iron levels in a biological sample, the molecule including an iron binding moeity and a signal generating moeity, wherein an intensity of the signal generated by the signal generating moeity is related to an amount of the iron bound by the iron binding moeity.